Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip De Keyser

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Rheumatology (Oxford, England)|February 19, 2011
Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approachJens T Van Praet, Katleen Van Steendam, Vanessa Smith, et al.
Arthritis and Rheumatism|July 30, 2005
Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunityLeen De Rycke, Anthony P Nicholas, Tineke Cantaert, et al.
Arthritis and Rheumatism|May 27, 2006
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritisElli Kruithof, Leen De Rycke, Bernard Vandooren, et al.
Microcirculation (New York, N.Y. : 1994)|April 19, 2016
Nailfold Capillaroscopy and Clinical Applications in Systemic SclerosisVanessa Smith, Kristof Thevissen, Amelia C Trombetta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodiesPeter G A Steenbakkers, Dominique Baeten, Eric Rovers, et al.
Annals of the Rheumatic Diseases|November 20, 2012
Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trialRené Westhovens, Filip De Keyser, Dmytro Rekalov, et al.
The Journal of Rheumatology|October 11, 2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activityBert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, et al.
Clinical and Experimental Rheumatology|July 28, 2016
Assessment of sensitivity to change of the European Scleroderma Study Group activity indexKarin Melsens, Filip De Keyser, Saskia Decuman, et al.
Arthritis Research & Therapy|May 19, 2005
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritisElli Kruithof, Dominique Baeten, Leen De Rycke, et al.
The Journal of Rheumatology|March 23, 2002
Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral)Ann VanderBorght, Filip De Keyser, Piet Geusens, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Rheumatology (Oxford, England)|February 19, 2011
Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approachJens T Van Praet, Katleen Van Steendam, Vanessa Smith, et al.
Arthritis and Rheumatism|July 30, 2005
Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunityLeen De Rycke, Anthony P Nicholas, Tineke Cantaert, et al.
Arthritis and Rheumatism|May 27, 2006
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritisElli Kruithof, Leen De Rycke, Bernard Vandooren, et al.
Microcirculation (New York, N.Y. : 1994)|April 19, 2016
Nailfold Capillaroscopy and Clinical Applications in Systemic SclerosisVanessa Smith, Kristof Thevissen, Amelia C Trombetta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodiesPeter G A Steenbakkers, Dominique Baeten, Eric Rovers, et al.
Annals of the Rheumatic Diseases|November 20, 2012
Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trialRené Westhovens, Filip De Keyser, Dmytro Rekalov, et al.
The Journal of Rheumatology|October 11, 2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activityBert Vander Cruyssen, André M M Miltenburg, Filip Van den Bosch, et al.
Clinical and Experimental Rheumatology|July 28, 2016
Assessment of sensitivity to change of the European Scleroderma Study Group activity indexKarin Melsens, Filip De Keyser, Saskia Decuman, et al.
Arthritis Research & Therapy|May 19, 2005
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritisElli Kruithof, Dominique Baeten, Leen De Rycke, et al.
The Journal of Rheumatology|March 23, 2002
Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral)Ann VanderBorght, Filip De Keyser, Piet Geusens, et al.
Pageof 11